TNF in Human Tuberculosis: A Double-Edged Sword

키워드

참고문헌 (93)

1. Russell DG, "Mycobacterium tuberculosis and the intimate discourse of a chronic infection", Immunol Rev, 240, pp.252~268 (2011)
2. Alsayed SSR, "Tuberculosis : pathogenesis, current treatment regimens and new drug targets", Int J Mol Sci, 24, pp.5202~ (2023)
3. Ruiz A, "Transmembrane TNF and its receptors TNFR1 and TNFR2 in mycobacterial infections", Int J Mol Sci, 22, pp.5461~ (2021)
4. Dostert C, "The TNF family of ligands and receptors : communication modules in the immune system and beyond", Physiol Rev, 99, pp.115~160 (2019)
5. Coppola M, "Cell-mediated immune responses to in vivo-expressed and stage-specific Mycobacterium tuberculosis antigens in latent and active tuberculosis across different age groups", Front Immunol, 11, pp.103~ (2020)
6. Beutler B, "Identity of tumour necrosis factor and the macrophage-secreted factor cachectin", Nature, 316, pp.552~554 (1985)
7. Carswell EA, "An endotoxin-induced serum factor that causes necrosis of tumors", Proc Natl Acad Sci U S A, 72, pp.3666~3670 (1975)
8. O’Malley WE, "Action of bacterial polysaccharide on tumors. Iii. repeated response of sarcoma 37, in tolerant mice, to serratia marcescens endotoxin", Cancer Res, 23, pp.890~895 (1963)
9. Baud V, "Signal transduction by tumor necrosis factor and its relatives", Trends Cell Biol, 11, pp.372~377 (2001)
10. Aggarwal BB, "Human tumor necrosis factor. Production, purification, and characterization", J Biol Chem, 260, pp.2345~2354 (1985)
11. Yang S, "Role of TNF-TNF receptor 2 signal in regulatory T cells and its therapeutic implications", Front Immunol, 9, pp.784~ (2018)
12. Bodmer JL, "The molecular architecture of the TNF superfamily", Trends Biochem Sci, 27, pp.19~26 (2002)
13. Chédotal H, "Small-molecule modulators of tumor necrosis factor signaling", Drug Discov Today, 28, pp.103575~ (2023)
14. Jacobs M, "Tumor necrosis factor receptor 2 plays a minor role for mycobacterial immunity", Pathobiology, 68, pp.68~75 (2000)
15. Shundo Y, "TNFR1 mediated apoptosis is protective against Mycobacterium avium in mice", Microorganisms, 11, pp.778~ (2023)
16. Roca FJ, "TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species", Cell, 153, pp.521~534 (2013)
17. Souza RF, "Study of tumor necrosis factor receptor in the inflammatory bowel disease", World J Gastroenterol, 29, pp.2733~2746 (2023)
18. Naudé PJ, "Tumor necrosis factor receptor cross-talk", FEBS J, 278, pp.888~898 (2011)
19. Wong KW, "The role of ESX-1 in Mycobacterium tuberculosis pathogenesis", Microbiol Spectr, 5 (2017)
20. Liu CH, "Innate immunity in tuberculosis : host defense vs pathogen evasion", Cell Mol Immunol, 14, pp.963~975 (2017)
21. Takeuchi O, "Pattern recognition receptors and inflammation", Cell, 140, pp.805~820 (2010)
22. Ray JC, "Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection", J Immunol, 182, pp.3706~3717 (2009)
23. Chai Q, "Host defense mechanisms against Mycobacterium tuberculosis", Cell Mol Life Sci, 77, pp.1859~1878 (2020)
24. Cadena AM, "Heterogeneity in tuberculosis", Nat Rev Immunol, 17, pp.691~702 (2017)
25. Kiran D, "Host-directed therapy targeting the Mycobacterium tuberculosis granuloma : a review", Semin Immunopathol, 38, pp.167~183 (2016)
26. Tsai MC, "Characterization of the tuberculous granuloma in murine and human lungs : cellular composition and relative tissue oxygen tension", Cell Microbiol, 8, pp.218~232 (2006)
27. Patel K, "Models of latent tuberculosis : their salient features, limitations, and development", J Lab Physicians, 3, pp.75~79 (2011)
28. Tonko S, "Length of hospital stay for TB varies with comorbidity and hospital location", Int J Tuberc Lung Dis, 24, pp.948~955 (2020)
29. Fearon KC, "Cancer cachexia : mediators, signaling, and metabolic pathways", Cell Metab, 16, pp.153~166 (2012)
30. Paval DR, "A systematic review examining the relationship between cytokines and cachexia in incurable cancer", J Cachexia Sarcopenia Muscle, 13, pp.824~838 (2022)
31. Balsano R, "Transforming growth factor-beta signaling in cancer-induced cachexia : from molecular pathways to the clinics", Cells, 11, pp.2671~ (2022)
32. Mupere E, "Wasting among Uganda men with pulmonary tuberculosis is associated with linear regain in lean tissue mass during and after treatment in contrast to women with wasting who regain fat tissue mass : prospective cohort study", BMC Infect Dis, 14, pp.24~ (2014)
33. Linge I, "Prolonged B-lymphocyte-mediated immune and inflammatory responses to tuberculosis infection in the lungs of TB-resistant mice", Int J Mol Sci, 24, pp.1140~ (2023)
34. Lopetuso LR, "Focus on anti-tumour necrosis factor(TNF)-α-related autoimmune diseases", Int J Mol Sci, 24, pp.8187~ (2023)
35. Wallis RS, "Tumour necrosis factor antagonists : structure, function, and tuberculosis risks", Lancet Infect Dis, 8, pp.601~611 (2008)
36. Keane J, "Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent", N Engl J Med, 345, pp.1098~1104 (2001)
37. Harris J, "Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis", J Infect Dis, 198, pp.1842~1850 (2008)
38. Mezouar S, "Tumor necrosis factor-alpha antagonist interferes with the formation of granulomatous multinucleated giant cells : new insights into Mycobacterium tuberculosis infection", Front Immunol, 10, pp.1947~ (2019)
39. Bo H, "Mycobacterium tuberculosis-macrophage interaction : molecular updates", Front Cell Infect Microbiol, 13, pp.1062963~ (2023)
40. Pattanaik KP, "Host-mycobacteria conflict : immune responses of the host vs. the mycobacteria TLR2 and TLR4 ligands and concomitant host-directed therapy", Microbiol Res, 264, pp.127153~ (2022)
41. Gopalakrishnan A, "Toll-like receptor 2 in host defense against Mycobacterium tuberculosis : to be or not to be-that is the question", Curr Opin Immunol, 42, pp.76~82 (2016)
42. Ruiz A, "DNA from virulent M. tuberculosis induces TNF-α production and autophagy in M1 polarized macrophages", Microb Pathog, 132, pp.166~177 (2019)
43. Nguyen H, "A role of intracellular toll-like receptors(3, 7, and 9)in response to Mycobacterium tuberculosis and co-infection with HIV", Int J Mol Sci, 21, pp.6148~ (2020)
44. Kwon KW, "Protective efficacy and immunogenicity of Rv0351", Rv3628 subunit vaccine formulated in different adjuvants against Mycobacterium tuberculosis infection, 2023, pp.23, e16~
45. Wang LX, "M2b macrophage polarization and its roles in diseases", J Leukoc Biol, 106, pp.345~358 (2019)
46. Ahmad F, "Macrophage : a cell with many faces and functions in tuberculosis", Front Immunol, 13, pp.747799~ (2022)
47. Rutschmann O, "Preexisting heterogeneity of inducible nitric oxide synthase expression drives differential growth of Mycobacterium tuberculosis in macrophages", MBio, 13, pp.e0225122~ (2022)
48. Chandra P, "Immune evasion and provocation by Mycobacterium tuberculosis", Nat Rev Microbiol, 20, pp.750~766 (2022)
49. Cambier CJ, "Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids", Nature, 505, pp.218~222 (2014)
50. Mohareer K, "Mycobacterial infection alters host mitochondrial activity", Int Rev Cell Mol Biol, 377, pp.87~119 (2023)
51. Mendonca LE, "Human alveolar macrophage metabolism is compromised during Mycobacterium tuberculosis infection", Front Immunol, 13, pp.1044592~ (2023)
52. Tukiman MH, "Immunometabolism of immune cells in mucosal environment drives effector responses against Mycobacterium tuberculosis", Int J Mol Sci, 23, pp.8531~ (2022)
53. Palma C, "Caloric restriction promotes immunometabolic reprogramming leading to protection from tuberculosis", Cell Metab, 33, pp.300~318 (2021)
54. Marrocco A, "Role of metabolic reprogramming in pro-inflammatory cytokine secretion from LPS or silica-activated macrophages", Front Immunol, 13, pp.936167~ (2022)
55. Mahla RS, "NIX-mediated mitophagy regulate metabolic reprogramming in phagocytic cells during mycobacterial infection", Tuberculosis(Edinb), 126, pp.102046~ (2021)
56. Ó Maoldomhnaigh C, "Lactate alters metabolism in human macrophages and improves their ability to kill Mycobacterium tuberculosis", Front Immunol, 12, pp.663695~ (2021)
57. van der Meer JW, "Trained immunity : a smart way to enhance innate immune defence", Mol Immunol, 68, pp.40~44 (2015)
58. Murphy DM, "The effects of trained innate immunity on T cell responses; clinical implications and knowledge gaps for future research", Front Immunol, 12, pp.706583~ (2021)
59. Netea MG, "Defining trained immunity and its role in health and disease", Nat Rev Immunol, 20, pp.375~388 (2020)
60. Rawat BS, "Therapeutic potentials of immunometabolomic modulations induced by tuberculosis vaccination", Vaccines(Basel), 10, pp.2127~ (2022)
61. Arts RJ, "Immunometabolic pathways in BCG-induced trained immunity", Cell Reports, 17, pp.2562~2571 (2016)
62. Koeken VA, "Plasma metabolome predicts trained immunity responses after antituberculosis BCG vaccination", PLoS Biol, 20, pp.e3001765~ (2022)
63. Stražar M, "The influence of the gut microbiome on BCG-induced trained immunity", Genome Biol, 22, pp.275~ (2021)
64. Bickett TE, "Characterizing the BCG induced macrophage and neutrophil mechanisms for defense against Mycobacterium tuberculosis", Front Immunol, 11, pp.1202~ (2020)
65. Espert L, "Autophagy in Mycobacterium tuberculosis and HIV infections", Front Cell Infect Microbiol, 5, pp.49~ (2015)
66. Klionsky DJ, "Autophagy as a regulated pathway of cellular degradation", Science, 290, pp.1717~1721 (2000)
67. Xu Y, "Emerging views of mitophagy in immunity and autoimmune diseases", Autophagy, 16, pp.3~17 (2020)
68. Kleinnijenhuis J, "Autophagy modulates the Mycobacterium tuberculosis-induced cytokine response", Immunology, 134, pp.341~348 (2011)
69. Anandaiah A, "Vitamin D rescues impaired Mycobacterium tuberculosis-mediated tumor necrosis factor release in macrophages of HIV-seropositive individuals through an enhanced Toll-like receptor signaling pathway in vitro", Infect Immun, 81, pp.2~10 (2013)
70. Bongiovanni B, "Effect of cortisol and", or DHEA on THP1-derived macrophages infected with Mycobacterium tuberculosis, 2015, pp.95, 562~569
71. Sharma N, "Mycobacterium tuberculosis protein PE6(Rv0335c), a novel TLR4 agonist, evokes an inflammatory response and modulates the cell death pathways in macrophages to enhance intracellular survival", Front Immunol, 12, pp.696491~ (2021)
72. Stanley SA, "Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth", PLoS Pathog, 10, pp.e1003946~ (2014)
73. Lee YJ, "Chemical modulation of SQSTM1", p62-mediated xenophagy that targets a broad range of pathogenic bacteria, 2022, pp.18, 2926~2945
74. Racanelli AC, "Autophagy and inflammation in chronic respiratory disease", Autophagy, 14, pp.221~232 (2018)
75. Nisa A, "Different modalities of host cell death and their impact on Mycobacterium tuberculosis infection", Am J Physiol Cell Physiol, 323, pp.C1444~ (2022)
76. Lam A, "Role of apoptosis and autophagy in tuberculosis", Am J Physiol Lung Cell Mol Physiol, 313, pp.L218~ (2017)
77. Mohareer K, "Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection", Tuberculosis(Edinb), 113, pp.99~121 (2018)
78. Jayaraman P, "IL-1β promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation", J Immunol, 190, pp.4196~4204 (2013)
79. Balcewicz-Sablinska MK, "Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha", J Immunol, 161, pp.2636~2641 (1998)
80. Satti I, "Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants", Nat Commun, 13, pp.6594~ (2022)
81. Saghazadeh A, "Central inflammatory cytokines in tuberculous meningitis : a systematic review and meta-analysis", J Interferon Cytokine Res, 42, pp.95~107 (2022)
82. Muefong CN, "Major neutrophil-derived soluble mediators associate with baseline lung pathology and post-treatment recovery in tuberculosis patients", Front Immunol, 12, pp.740933~ (2021)
83. Sampath P, "Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity", Sci Rep, 13, pp.785~ (2023)
84. Téllez-Navarrete NA, "Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and-resistant tuberculosis : however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time", Mol Med, 27, pp.76~ (2021)
85. Mily A, "Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes", BMC Infect Dis, 20, pp.933~ (2020)
86. Tezera LB, "Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α", eLife, 9, pp.e52668~ (2020)
87. Wang Y, "Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas", J Infect, 86, pp.421~438 (2023)
88. Remijsen Q, "Depletion of RIPK3 or MLKL blocks TNF-drivennecroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis", Cell Death Dis, 5, pp.e1004~ (2014)
89. Xu G, "Insights into battles between Mycobacterium tuberculosis and macrophages", Protein Cell, 5, pp.728~736 (2014)
90. Cui Y, "Mycobacterium tuberculosis protease Rv3090 is associated with late cell apoptosis and participates in organ injuries and mycobacterial dissemination in mice", Microb Pathog, 173, pp.105880~ (2022)
91. Roca FJ, "TNF induces pathogenic programmed macrophage necrosis in tuberculosis through a mitochondrial-lysosomal-endoplasmic reticulum circuit", Cell, 178, pp.1344~1361 (2019)
92. Roca FJ, "Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport", Science, 376, pp.eabh2841~ (2022)
93. Kim TS, "SIRT3 promotes antimycobacterial defenses by coordinating mitochondrial and autophagic functions", Autophagy, 15, pp.1356~1375 (2019)

관련 논문AI추천